News

July 5, 2017July 5, 2017

Loss of NLRX1 Gene May Contribute to Bowel Disease Development, Study Shows

A gene called NLRX1 plays a crucial role in inhibiting the abnormal immune system response to gastrointestinal inflammation that occurs in bowel disease, according to a study. Loss of the ... Read more

June 30, 2017June 30, 2017

Researchers Produce Genetic Map to Help Determine IBD Causes

News

Researchers are narrowing in on the specific genes that are responsible for inflammatory bowel disease (IBD), a discovery that could lead to better treatment strategies and new therapy targets. ... Read more

June 29, 2017

In Celebration of Canada 150, Crohn’s and Colitis Canada and AbbVie Add IBD Scholarships

News

To celebrate Canada 150, Crohn’s and Colitis Canada and AbbVie have announced there will be five additional IBD Scholarships of up to $5,000 to be awarded to students who ... Read more

June 28, 2017

Researchers Identify Fungus That May Worsen Crohn’s Disease Symptoms

News

The fungus Candida tropicalis may trigger gut inflammation and worsen Crohn’s disease, according to results of a study presented at this year’s Digestive Disease Week, held recently in Chicago. ... Read more

June 27, 2017

Treatment Ends in Trial Showing That Brilacidin Is Effective Against Bowel Disease

News

Treatment has been completed in a Phase 2 clinical trial of brilacidin for ulcerative proctitis and ulcerative proctosigmoiditis — a study that led to six of the 12 patients’ ... Read more

June 26, 2017

EMA Committee Urges Approval of Humira Biosimilar Imraldi to Treat IBDs

News

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion regarding on marketing authorization for Imraldi (adalimumab), a biosimilar candidate referencing Humira. The ... Read more

June 23, 2017June 24, 2017

Swiss Regulators to Consider Cx601 as a Treatment for Crohn’s-related Anal Fistulas

News

Swiss regulators have agreed to review Cx601 as a treatment for Crohn’s-disease-related skin sores known as complex perianal fistulas. The Swiss Agency for Therapeutic Products, or Swissmedic, granted orphan drug status to the ... Read more

June 22, 2017June 22, 2017

Glepaglutide Improves Short Bowel Syndrome Patients’ Ability to Get Nutrients from Food, Trial Shows

News

Zealand Pharma‘s glepaglutide (ZP1848) improves short bowel syndrome patients’ ability to absorb nutrients from food, according to a Phase 2 clinical trial. The condition, also known as SBS, occurs ... Read more

June 21, 2017

Protein gp96 Essential for Normal Inflammatory Response in the Gut, Study Finds

News

Researchers at the Medical University of South Carolina (MUSC) found that a protein called gp96 is necessary for normal function and balance of the resident immune cells in the ... Read more

June 20, 2017June 20, 2017

Britain’s NICE Recommends Janssen’s Stelara as New Treatment for Crohn’s Disease

News

The United Kingdom’s National Health Service (NHS) is about to grant access to Stelara (ustekinumab) as a new treatment for Crohn’s disease, after a positive National Institute for Health and ... Read more